Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...

Abbott Laboratories is back in focus after several research houses reset their price targets, with some cuts in the US$5 to US$29 range and at least one target lifted into the mid US$150s. Those moves ...

A massive study found that eating after a specific evening hour raises cardiovascular risk by 28% — and the cutoff is earlier than most people expect. But the hardest part isn't the science. It's what ...

Even "normal" kidney test results may mask hidden risks if theyre unusually low for your age and sex, signaling higher chances of future disease.

In debates about the soaring costs of American health care, attention typically turns to insurance reform, pharmaceutical ...

Q: I'm confused. You say it's bad to eat red meat and whole dairy, but now they are at the top of the new food pyramid. What gives? -- Frankie T., Denver ...

International Equities added another 5% in the fourth quarter, finishing up over 30% for the year, the largest gain since ...

Historical evidence indicates that abrupt market fluctuations can affect any corporation, regardless of its perceived dominance.

As I moved into my early fifties, with a family history of diabetes on one side and colon cancer on the other, I realised I wanted more than reassurance, I wanted understanding. That is what led me to ...

The AAR held that Dry Citrate Powder used in haemodialysis is not an instrument or apparatus under Chapter 90. It was classified under HSN 29181590 as an organic chemical, attracting 18% ...

Research and development (R&D) are essential elements of Eli Lilly’s operations, enabling the company to remain at the ...

Rolling coverage of the latest economic and financial news ...